CC趋化因子配体20在肝细胞癌组织中的表达及其在肝细胞肝癌预后评估中作用的生物信息学分析

doi:10.13481/j.1671-587X.20220422

Abstract

Abstract: Objective

To investigate the expression of CC chemokine ligand 20 （CCL20） in liver hepatocellular carcinoma（LIHC） tissue and explore its influence in the prognosis in the patients with LIHC， and to elucidate the mechanism of CCL20 affecting the malignant behavior of LIHC. Methods The mRNA expression levels and clinical data in cancer tissue and para-cancer tissue of the LIHC patients were obtained from The Cancer Genome Atlas （TCGA） and UCSC Xena platforms using Rstudio （4.03） software， and the differences in the CCL20 mRNA expression between the two kinds of tissues were compared，and these results were validated using GEPIA combined with GTEx data. Kaplan-Meier survival analysis and Cox regression analysis methods were used to analyze the relationship between the CCL20 mRNA expression level and the prognosis of LIHC patients. The correlation between the CCL20 expression level and alpha fetoprotein （AFP） level in the LIHC patients was analyzed by Pearson correlation analysis， and the area under receiver operating characteristic （ROC） curve（AUC）， Nomogram and correction curve were used to analyze the correlations between the CCL20 mRNA expression level and the clinical diagnosis and survival prediction in the patients with LIHC. GSEA enrichment analysis of the CCL20 mRNA correlation between the expression level expression in cancer tissue of the LIHC patients was performed using the TCGA database， and the correlation between the expression level of CCL20 mRNA and DNA copy-number alterations（CNA） and DNA methylation level were analyzed.

Results

Compared with para-cancer tissue，the CCL20 mRNA expression level in cancer tissue of the LIHC patients was significantly increased（P<0.01）.The Kaplan-Meier survival analysis results showed that the patients with low expression of CCL20 mRNA had a significantly better prognosis than those with high expression of CCL20 mRNA （HR=1.789， P<0.01）. The Cox univariate and multifactorial regression analysis results showed that the CCL20 mRNA expression level was an independent prognostic factor of the LIHC patients（P<0.05）； the Pearson correlation analysis showed a positive correlation between the CCL20 mRNA expression levels and AFP levels in cancer tissue of the LIHC patients （P<0.01）. The CCL20 mRNA expression level had certain reference value in assessment of clinical diagnosis of the LIHC patients（AUC=0.69，P<0.01）， and could effectively predict the survival rate of the LIHC patients. The GSEA analysis showed that CCL20 could be involved in LIHC cell adhesion， cytokine-cytokine receptor interaction and ribosome function implementation through chemokine， NOD-like receptor（NLR）， PPAR and Toll-like receptor（TLR） tumor-related signaling pathways. The genetic and epigenetic analysis showed that compared with normal diploid sample group， the expression levels of CCL20 mRNA in copy number loss group and copy number amplification group had no significant differences（P>0.05）；compared with copy number loss group，the CCL20 mRNA expression level in copy number amplification group was significantly increased（P<0.05）；the expression level of CCL20 mRNA was negatively correlated with its DNA methylation level （cor=－0.11，P<0.05）.

Conclusion

The CCL20 expression upregulation in LIHC tissue is significantly associated with the poor prognosis of LIHC patients， which can be involved in the malignant process of LIHC through multiple signaling pathways， and it can be used as one of the indicators for prognostic assessment and prediction of survival of the LIHC patients.

Key words: CC chemokine ligand 20, Liver hepatocellular carcinoma, Bioinformatics analysis, Prognosis, Clinical diagnosis

CLC Number:

R735.7

Liantao HU,Wenjun DENG,Shizhen LU,Luo SUN,Xuebing LI,Chuhao LI,Xinran WANG,chunbing ZHANG,Yue LI,Weiqun WANG. Bioinformatics analysis on CC chemokine ligand 20 expression in hepatocellular carcinoma tissue and its effect on prognostic assessment of liver hepatocellular carcinoma[J].Journal of Jilin University(Medicine Edition), 2022, 48(4): 1010-1017.

Figures/Tables 6

Fig. 1

Fig. 2

Tab. 1

Fig. 3

Fig. 4

Fig. 5

References 30

1	BRAY F， FERLAY J， SOERJOMATARAM I， et al. Global cancer statistics 2018： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin， 2018， 68（6）： 394-424.
2	BARBARIC J， SEKERIJA M， AGIUS D， et al. Disparities in melanoma incidence and mortality in South-Eastern Europe： increasing incidence and divergent mortality patterns. Is progress around the corner？［J］. Eur J Cancer， 2016， 55： 47-55.
3	HUANG F， GENG X P. Chemokines and hepatocellular carcinoma［J］. World J Gastroenterol， 2010， 16（15）： 1832-1836.
4	DING X J， WANG K X， WANG H， et al. High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection［J］. J Gastrointest Surg， 2012，16（4）： 828-836.
5	LEE A Y， PHAN T K， HULETT M D， et al. The relationship between CCR6 and its binding partners： does the CCR6-CCL20 axis have to be extended？［J］. Cytokine， 2015， 72（1）： 97-101.
6	WILLIAMS I R. CCR6 and CCL20： partners in intestinal immunity and lymphorganogenesis［J］. Ann N Y Acad Sci， 2006， 1072： 52-61.
7	ACOSTA-RODRIGUEZ E V， RIVINO L， GEGINAT J， et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells［J］. Nat Immunol， 2007， 8（6）： 639-646.
8	GUO W B， LI H， LIU H， et al. DEPDC1 drives hepatocellular carcinoma cell proliferation， invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway［J］. Oncol Rep， 2019， 42（3）： 1075-1089.
9	WANG Z N， JENSEN M A， ZENKLUSEN J C. A practical guide to the cancer genome atlas（TCGA）［J］. Methods Mol Biol， 2016， 1418： 111-141.
10	TANG Z F， LI C W， KANG B X， et al. GEPIA： a web server for cancer and normal gene expression profiling and interactive analyses［J］. Nucleic Acids Res， 2017， 45（W1）： W98-W102.
11	SHEN Y， PENG X W， SHEN C L. Identification and validation of immune-related lncRNA prognostic signature for breast cancer［J］. Genomics，2020，112（3）： 2640-2646.
12	WU M W， LI X B， ZHANG T P， et al. Identification of a nine-gene signature and establishment of a prognostic nomogram predicting overall survival of pancreatic cancer［J］. Front Oncol， 2019， 9： 996.
13	ZHANG D L， ZHOU H G， LIU J， et al. Long noncoding RNA ASB16-AS1 promotes proliferation， migration， and invasion in glioma cells［J］. Biomed Res Int， 2019， 2019： 5437531.
14	ZHANG Y， HONG Y K， ZHUANG D W， et al. Bladder cancer survival nomogram： development and validation of a prediction tool， using the SEER and TCGA databases［J］.Medicine （Baltimore），2019，98（44）： e17725.
15	BI K W， WEI X G， QIN X X， et al. BTK has potential to be a prognostic factor for lung adenocarcinoma and an indicator for tumor microenvironment remodeling： a study based on TCGA data mining［J］. Front Oncol， 2020， 10： 424.
16	LEE H J， LEE H Y， LEE J H， et al. Prognostic significance of biallelic loss of PTEN in clear cell renal cell carcinoma［J］. J Urol， 2014， 192（3）： 940-946.
17	SCHOBER P， BOER C， SCHWARTE L A. Correlation coefficients： appropriate use and interpretation［J］. Anesth Analg， 2018， 126（5）： 1763-1768.
18	BENKHEIL M， PAESHUYSE J， NEYTS J， et al. HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesis［J］. Biochem Pharmacol， 2018， 155： 305-315.
19	BENKHEIL M， MVAN HAELE， ROSKAMS T，et al. CCL20， a direct-acting pro-angiogenic chemokine induced by hepatitis C virus （HCV）： potential role in HCV-related liver cancer［J］.Exp Cell Res，2018，372（2）：168-177.
20	ANNUNZIATO F， COSMI L， SANTARLASCI V， et al. Phenotypic and functional features of human Th17 cells［J］. J Exp Med， 2007， 204（8）： 1849-1861.
21	PICKUP M W， MOUW J K， WEAVER V M. The extracellular matrix modulates the hallmarks of cancer［J］. EMBO Rep， 2014， 15（12）： 1243-1253.
22	张海利，李娟芳，李晓晴，等. CCR6通过上皮间质转化促进结直肠癌肝转移的机制研究［J］. 国际肿瘤学杂志， 2020， 47（1）： 29-34.
23	CREMEL M， BERLIER W， HAMZEH H， et al. Characterization of CCL20 secretion by human epithelial vaginal cells： involvement in Langerhans cell precursor attraction［J］. J Leukoc Biol， 2005， 78（1）： 158-166.
24	OZAKYOL A. Global epidemiology of hepatocellular carcinoma （HCC epidemiology）［J］. J Gastrointest Cancer， 2017， 48（3）： 238-240.
25	NEDOSZYTKO B， LANGE M， SOKOŁOWSKA-WOJDYŁO M， et al. The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part Ⅰ：Treg properties and functions［J］.Postepy Dermatol Alergol， 2017， 34（4）： 285-294.
26	MUSCELLA A， VETRUGNO C， MARSIGLIANTE S.CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture［J］. Mol Carcinog， 2017， 56（11）： 2461-2473.
27	KAPUR N， MIR H， CLARK III C E， et al. CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition［J］. Br J Cancer， 2016， 114（12）： 1343-1351.
28	CAMPBELL D J， KOCH M A. Phenotypical and functional specialization of FOXP3+regulatory T cells［J］. Nat Rev Immunol， 2011， 11（2）： 119-130.
29	赵阳，周林，贺强. CD8⁺调节性T细胞诱导移植免疫耐受的研究进展［J］. 解放军医学院学报， 2020， 41（7）： 743-745， 751.
30	FUJII H， ITOH Y， YAMAGUCHI K， et al. Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro ［J］. Biochem Biophys Res Commun， 2004， 322（3）：1052-1058.

Variable	Univariate analysis		Multivariate analysis
Variable	HR (95% CI)	P	HR (95% CI)	P
Age (≥ 65 years old vs < 65 years old)	1.23(0.85－1.78)	0.273	－	－
Gender (Female vs Male)	1.26(0.87－1.84)	0.228	－	－
Family history of cancer (Yes vs No)	1.14(0.76－1.69)	0.530	－	－
TNM stage (Ⅱ vs Ⅰ)	1.42(0.87－2.32)	0.160	1.47(0.90－2.40)	0.123
TNM stage (Ⅲ vs Ⅰ)	2.72(1.78－4.15)	<0.001	2.76(1.80－4.23)	<0.001
TNM stage (Ⅳ vs Ⅰ)	5.44(1.68－17.63)	0.005	5.51(1.70－17.89)	0.004
Histologic grade (G3-G4 vs G1-G2)	1.14(0.78－1.67)	0.489	－	－
Ishak score (5－6 vs 0－4)	0.87(0.50－1.50)	0.612	－	－
Child-Pugh grade (B-C vs A)	1.66(0.82－3.36)	0.159	－	－
AFP(Positive vs Negative)	1.45(0.92－2.28)	0.108	－	－
Residual tumor (R1-R2 vs R0)	1.17(0.43－3.20)	0.754	－	－
CCL20 (High vs Low)	1.07(1.00－1.14)	0.045	1.07(1.01－1.14)	0.034

[1]	Xiaohui LIANG,Wenna LIU,Jianbo ZHAO. Bioinformatic analysis on PAQR3 expression in hepatocellular carcinoma and its correlations with T lymphocyte infiltration, immune checkpoint genes, and patient survival [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 781-790.
[2]	Yu LIANG,Jinyu YU,Zhonggao XU,Wanning WANG. Expression characteristics of FOSB in kidney tissue from IgA nephropathy and other common kidney diseases [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1281-1292.
[3]	Ming CHEN,Qinghua LUO,Hongguang JIN,Liang HAN. Atypical lipomatous tumor of left lower limb: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1384-1389.
[4]	Ziru ZHOU,Mengfei SUN,Huakun ZHANG,Shuyan SUN,Qi SUN,Feng LI,Yunzhao CHEN,Jie YU,Yuwen CAO,Xiaobin CUI. Expression of Rh family C glycoprotein in esophageal squamous carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1019-1027.
[5]	Xialing HUANG,Dandan ZHANG,Xuemei ZHANG. Analysis on relationship between methylation of MSX1 gene and clinical pathological features and prognosis of patients with cervical cancer [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 749-756.
[6]	Wenchang CAI,Yuqi LIU,Han WANG,Helin WANG,Zhenjiang WANG,Zishen XIAO,Shiyuan MA,Liping AN,Yanbo LIU. Expression of protein kinase D2 in bladder cancer tissue and its effect on tumor immune microenvironment [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 378-391.
[7]	Xiaoyan WANG,Xuelian LI,Bin LIANG,Wenfei TIAN,Hailin MA,Zhijing MO. Analysis on relationship between CALU and prognosis of hepatocellular carcinoma patients and its mechanism based on transcriptome and single cell sequencing data [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 447-459.
[8]	Haiying GENG,Yan YU,Chunmei DAI,Youfeng WEN,Ning LI. Expression of TRIM24 protein in human clear cell renal cell carcinoma tissue and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 486-492.
[9]	Xi YANG,Qin YUAN,Lan YANG,Wenjie ZHANG. Bioinformatics analysis on PDE1B expression and prognosis of gastric cancer and tumor microenvironment [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1664-1676.
[10]	Jiaxin YI,Yangyu ZHANG,Yingli FU,Yuchen PAN,Yongjie HAN,Jing JIANG,Yanhua WU. Effect of MEIS1 expression on survival in patients after radical gastrectomy and its value in prognostic evaluation [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1358-1364.
[11]	Chaojie GUO,Jiajia ZHANG,Jie ZENG,Huiyu WANG, AIERFATI·Aimaier,Jiang XU. Expressions of PLOD1 in oral squamous cell carcinoma tissue and cells and their significances [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1035-1043.
[12]	Yuanguo WANG,Peng ZHANG. Bioinformatics analysis based on relationship between SSP1 and TGFB1 and occurrence, prognosis, and immune invasion of esophageal adenocarcinoma [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1076-1086.
[13]	Yueying SONG,Chao GAO,Wenjun CHEN,Aiyu SHAO,Yichun QIAO,Zhuolin LI. Screening of miRNAs related to prognosis of triple-negative breast cancer and its gene network based on TCGA Database [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 392-399.
[14]	Yaqi XU,Yanyu WANG,Wenjing ZHANG,Mei HAN,Huaxia MU,Xi YANG,Weixiao BU,Zikun TAO,Yujia KONG,Fuyan SHI,Suzhen WANG. Bioinformatics analysis on screening of key genes of hepatitis B virus-related hepatocellular carcinoma and its relationship with prognosis [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1243-1252.
[15]	Haikang CUI,Xudong ZHANG,Xiaoning LI,Xi YANG,Lan YANG,Wenjie ZHANG. Bioinformatics analysis on predition effect of subtypes of cell pyroptosis and APOD on prognosis of gastric cancer patients [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1268-1279.

Bioinformatics analysis on CC chemokine ligand 20 expression in hepatocellular carcinoma tissue and its effect on prognostic assessment of liver hepatocellular carcinoma

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 6

References 30

Related Articles 15

Metrics

Comments

Recommended 10